BMPR2 and pulmonary arterial hypertension: Further, for PAH due to BMPR2 (Bone morphogenetic protein receptor type II, serine/threonine receptor kinase) loss-of-function mutations or downregulation in pulmonary ECs, RNA sequencing and Ca2+ imaging data showed a link to the P2 receptor Ca2+-signalosome [32].